sefulness of platelet concentrate dressing for the healing of diabetic foot ulcers
Not Applicable
- Conditions
- Health Condition 1: null- Patients with diabetic foot ulcers
- Registration Number
- CTRI/2018/04/013411
- Lead Sponsor
- Self sponsored
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.persons with type1 or type2 diabetes with denovo lower extremity diabetic ulcers
2.male and female,between ages 18-95
3.ulcer of atleast 4weeks duration with post debridement free of sinus tracts and tunneling and atleast 4cms from any additional wound
4.HbA1C <12
5.Wound measurement between 0.5 - 20 sqcm
6.full thickness without exposure of bone, muscle, ligament, tendon
7.the limb had to have adequate perfusion via ABI between 0.8 -1.5
8.no H/O infectious disorders in last 6 months
9.informed consent form signed
Exclusion Criteria
1. Non pregnant and non lactating women
2. Not on suppressants and ART
3. Ulcers of venous and arterial insufficiency
4. Bleeding and Clotting disorders
5. Patients on chemo and radiotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Time to healthy granulation tissue formation <br/ ><br>2. Number of debridement and dressings <br/ ><br>3. reduction in the ulcer size <br/ ><br>4. SSG graft uptake <br/ ><br>5. Adverse reactionsTimepoint: Fifth day and ninth day after intervention
- Secondary Outcome Measures
Name Time Method SSG graft uptake for the intervention armTimepoint: 5th day, 9th day